DK0697876T3 - Xenograftthymus - Google Patents

Xenograftthymus

Info

Publication number
DK0697876T3
DK0697876T3 DK94917424T DK94917424T DK0697876T3 DK 0697876 T3 DK0697876 T3 DK 0697876T3 DK 94917424 T DK94917424 T DK 94917424T DK 94917424 T DK94917424 T DK 94917424T DK 0697876 T3 DK0697876 T3 DK 0697876T3
Authority
DK
Denmark
Prior art keywords
thymus
xenograft
donor
engraftment
proliferation
Prior art date
Application number
DK94917424T
Other languages
Danish (da)
English (en)
Inventor
Megan Sykes
David H Sachs
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of DK0697876T3 publication Critical patent/DK0697876T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Glass Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK94917424T 1993-05-17 1994-05-16 Xenograftthymus DK0697876T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6294693A 1993-05-17 1993-05-17
US16391293A 1993-12-07 1993-12-07
PCT/US1994/005528 WO1994026285A1 (en) 1993-05-17 1994-05-16 Xenograft thymus

Publications (1)

Publication Number Publication Date
DK0697876T3 true DK0697876T3 (da) 2002-09-09

Family

ID=26742900

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94917424T DK0697876T3 (da) 1993-05-17 1994-05-16 Xenograftthymus

Country Status (10)

Country Link
EP (1) EP0697876B1 (ja)
JP (1) JP3553941B2 (ja)
AT (1) ATE222111T1 (ja)
AU (1) AU694120B2 (ja)
CA (1) CA2161797A1 (ja)
DE (1) DE69431184T2 (ja)
DK (1) DK0697876T3 (ja)
ES (1) ES2179846T3 (ja)
PT (1) PT697876E (ja)
WO (1) WO1994026285A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002030259A2 (en) * 2000-10-13 2002-04-18 Monash University Disease prevention by reactivation of the thymus
WO2002030351A2 (en) * 2000-10-13 2002-04-18 Monash University Improvement of graft acceptance through manipulation of thymic regeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087570A (en) * 1988-05-10 1992-02-11 Weissman Irving L Homogeneous mammalian hematopoietic stem cell composition

Also Published As

Publication number Publication date
PT697876E (pt) 2002-11-29
JP3553941B2 (ja) 2004-08-11
EP0697876A4 (en) 1997-09-10
CA2161797A1 (en) 1994-11-24
EP0697876A1 (en) 1996-02-28
AU6915794A (en) 1994-12-12
DE69431184T2 (de) 2003-03-27
ES2179846T3 (es) 2003-02-01
EP0697876B1 (en) 2002-08-14
WO1994026285A1 (en) 1994-11-24
JPH09500364A (ja) 1997-01-14
DE69431184D1 (en) 2002-09-19
AU694120B2 (en) 1998-07-16
ATE222111T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
HUS1400034I1 (hu) Dialkil-fumarátok alkalmazása autoimmun betegségek kezelésére szolgáló gyógyászati készítmények elõállítására
GEP20022648B (en) Method for Inducing T Cell Tolerance to a Tissue or Organ Graft
AR009560A1 (es) Prolongacion de la sobrevida de injertos con porfirinas
ATE497738T1 (de) Verzweigtes prosthetisches transplantat
ES2170096T3 (es) Uso de lineas celulares fetales neuroderivadas para terapia de trasplantes.
EP0369216A3 (en) Pharmaceutical preparation based on ester derivatives of hecogenine, and their use in treating benign prostatic hyperplasia
DK0697876T3 (da) Xenograftthymus
DE3875306D1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
WO1993006852A3 (en) Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein
EP0971725A4 (en) METHOD FOR TREATING SCAR TISSUE
EP1100515A4 (en) $ I (EX VIVO) TREATMENT OF ALLOGENIC AND XENOGENIC T CELLS USING gp39 ANTAGONISTS
ES2186411T3 (es) Antagonista de receptor de quimioquinas y ciclosporina en terapia combinada.
ATE243518T1 (de) 5-androsten 3-beta, 17-alpha diol als tumorwachstumshemmer
HK1035206A1 (en) Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum.
RU93025273A (ru) Способ закрытия обширных дефектов кожи черепа
ATE253378T1 (de) Xenogene transplantation
UA28362A (uk) Спосіб лікування цукрового діабету в експерименті